Glooko

Glooko is a universal diabetes management platform designed to enhance health outcomes for individuals with diabetes and their healthcare teams. The platform integrates with a wide range of diabetes devices and fitness trackers, allowing for the collection of vital patient data, including glucose levels, medication usage, blood pressure, and dietary information. By providing personalized and timely insights, Glooko supports remote patient monitoring and facilitates interventions aimed at improving patient care. The platform is utilized in over 7,000 clinical locations and is trusted by more than 1.5 million users across 23 countries and 15 languages. Through its comprehensive data synchronization and analytics capabilities, Glooko aims to drive behavior change and optimize diabetes management.

Sam Wynbrandt

Director, Product Management

2 past transactions

Diasend

Acquisition in 2016
Diasend AB is a company specializing in diabetes data management, providing a system that allows users to upload and consolidate information from glucose meters, insulin pumps, continuous glucose monitoring (CGM) devices, and mobile applications. Its main offerings include the diasend system, which generates comprehensive reports, diasend Clinic for healthcare providers to collect and store patient data, and diasend Personal for individuals with diabetes to upload their device data. Additionally, Diasend offers an electronic medical record (EMR) interface that ensures interoperability by integrating data from various diabetes management devices into healthcare providers' systems. Founded in 2004 and originally known as Aidera AB, the company changed its name in 2012 and is headquartered in Askim, Sweden, with additional locations in Chicago and Barcelona. Diasend's solutions are FDA approved and CE marked, and the company operates in 23 countries, facilitating easier access to diabetes management information for patients and healthcare professionals alike.

Glooko

Series A in 2014
Glooko is a comprehensive diabetes management platform designed to enhance health outcomes for individuals with diabetes and their healthcare teams. It connects with various diabetes devices and fitness trackers to gather essential data, including glucose levels, food intake, insulin usage, medications, blood pressure, diet, and weight. The platform is utilized in over 7,000 clinical locations and serves more than 1.5 million people with diabetes across 23 countries and in 15 languages. Glooko aims to facilitate remote patient monitoring by providing healthcare providers with valuable insights and analytics, ultimately supporting interventions that improve patient care and promote healthier behaviors.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.